Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

14.71
Delayed Data
As of Oct 16
 -0.27 / -1.80%
Today’s Change
14.30
Today|||52-Week Range
44.42
-59.42%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Generic
MARKET CAP
$15.2B

Company Description

Teva Pharmaceutical Industries Ltd. is a global pharmaceutical company, which provides patient-centric healthcare solutions. It operates through two segments: Generic Medicines and Specialty Medicines. The Generic Medicines segment includes chemical and therapeutic equivalents of originator medicines in a variety of dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments and creams. The Specialty Medicine segment engages in the provision of core therapeutic areas of central nervous system medicines. The company was founded in 1901 and is headquartered in Petach Tikva, Israel.

Contact Information

Teva Pharmaceutical Industries Ltd.
5 Basel Street
Petach Tikva Hamerkaz 49131
P:(723) 926-7267
Investor Relations:
(215) 591-8912

Employees

Shareholders

Mutual fund holders31.99%
Other institutional26.55%
Individual stakeholders--

Top Executives

Kåre SchultzPresident & Chief Executive Officer
Carlo de NotaristefaniPresident & CEO-Global Operations
Michael McClellanChief Financial Officer
Michael R. HaydenChief Scientific Officer
Eric DrapéExecutive Vice President & Head-Quality